Zenas Biopharma Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$19.78

+1.20 (+6.46%)

As of Jun 21, 10:15 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 2 14%

Sell 0 0%

Price Target

Analyst Price Target +49.2% upside

Low Target $22.12

Average Target $29.51

High Target $35.27

Current Price $19.78

Current
$19.78

Target
$29.51

$22.12 $29.51 avg $35.27

Scenario Analysis

Bear Case

$22.12

11.8%

Low target

Base Case

$29.51

+49.2%

Avg target

Bull Case

$35.27

+78.3%

High target

Risk/Reward

6.6x

Highly favorable

Price in Context

52-Week High

$44.60

-55.7% from high

52-Week Low

$8.91

+122.0% from low

Target vs 52W High

$29.51

-33.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+5.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-46.4%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+191.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-9.5%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-36.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.5%